The role of natalizumab in the treatment of multiple sclerosis.

The American journal of managed care

Volumn 16, Issue 6 Suppl, 2010, Pages

  Coyle, Patricia K ^a  

^a STONY BROOK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTEGRIN; MONOCLONAL ANTIBODY; NATALIZUMAB;

CLINICAL TRIAL; DISEASE COURSE; DRUG ANTAGONISM; HUMAN; MULTIPLE SCLEROSIS; PATHOPHYSIOLOGY; REVIEW;

ANTIBODIES, MONOCLONAL; CLINICAL TRIALS AS TOPIC; DISEASE PROGRESSION; HUMANS; INTEGRIN ALPHA CHAINS; MULTIPLE SCLEROSIS;

EID: 77958123700     PISSN: None     EISSN: 19362692     Source Type: Journal    
DOI: None     Document Type: Review

References (0)